Code list: res22: screen

Research article:

Breast and cervical cancer screening utilization, and recording bias, in women with type 2 diabetes (UK)

Reference:

Matthew Carr, Evan Kontopantelis, Tim Doran, Christine Campbell, Lorraine Lipscombe, Emma Crosbie, Anthony Howell, Iain E Buchan, Andrew G Renehan (2015) Breast and cervical cancer screening utilization, and recording bias, in women with type 2 diabetes (UK). Diabetologia, doi:

Link to article
Abstract: Aims/hypothesis: Studies from healthcare databases suggest that patients with type 2 diabetes (T2D) under-utilize cancer screening opportunities, but recording bias may be a problem. We evaluated the relative effect of T2D on screening utilization trends among long-established UK national programmes in breast and cervical cancers; and tested the impact of introducing a primary care financial incentive scheme (QOF) in 2004, known to improve data recording for diabetes-related care. Materials and methods: Using the Clinical Practice Research Datalink, we identified women with prevalent T2DM (N = 174,256), separately by year for 1999 to 2011, and eligible for screening events for breast (aged 50-70 years) and cervical (aged 35-49 and 50-64 years) cancers. We described secular trends and compared these with the non-diabetes population, and accounted for co-morbidities using matched conditional logistic regression models. We performed interrupted time-series (ITS) analyses to assess the impact of the QOF introduction. Results: Compared with the non-diabetes population, relative uptake rates for breast and cervical screening were generally similar in patients with T2D pre-2004, becoming greater for years post-2004. These patterns were unaffected by adjustment for GP practice, and were not accounted for by T2D associated co-morbidities. ITS analysis showed increased activities in all three screening groups for 2007, but these broadly returned to pre-2004 trends by 2011, paralleling similar patterns in recording for other care provision indicators. Conclusions/interpretation: In this population, we found no evidence that women with T2D under-utilize breast and cervical cancer screening opportunities. A financial incentive scheme was associated with intermediate-term improvements in screening utilization, but this is likely to reflect improved recording of care events.
Author for correspondence: Andrew Renehan
Email for correspondence: arenehan@picr.man.ac.uk

Code list: res22: screen_breast

50 codes in list

Code	Coding system	Description	Entity type	List name
1A81.00	Read	No breast lump	test	res22: screen_breast
1A82.00	Read	Breast lump present	test	res22: screen_breast
1A84.00	Read	Breast lump detected by mammogram	test	res22: screen_breast
537..00	Read	Soft tissue X-ray breast	test	res22: screen_breast
5371.00	Read	Mammography requested	test	res22: screen_breast
537..11	Read	Mammography - X-ray	test	res22: screen_breast
5372.00	Read	Mammography normal	test	res22: screen_breast
5373.00	Read	Mammography abnormal	test	res22: screen_breast
5374.00	Read	Mammography offered	test	res22: screen_breast
5376.00	Read	Mammography attended	test	res22: screen_breast
537Z.00	Read	Soft tissue X-ray breast NOS	test	res22: screen_breast
54L3.00	Read	Mammary gland contrast radiog.	test	res22: screen_breast
54L3.11	Read	Breast contrast radiog	test	res22: screen_breast
54L3.12	Read	Mammary contrast radiog	test	res22: screen_breast
56B1.00	Read	Specific mammary gland imaging	test	res22: screen_breast
585C.00	Read	US scan of breast	test	res22: screen_breast
5861.00	Read	Thermography - breast	test	res22: screen_breast
5861.11	Read	Mammogram-thermographic	test	res22: screen_breast
6862.00	Read	Breast neoplasm screen	test	res22: screen_breast
6862000	Read	Breast neoplasm screen normal	test	res22: screen_breast
6862100	Read	Breast neoplasm screen abnorm	test	res22: screen_breast
6862.11	Read	Mammography - screening	test	res22: screen_breast
6862Z00	Read	Breast neoplasm screen NOS	test	res22: screen_breast
6865.00	Read	Breast neoplasm screen normal	test	res22: screen_breast
7P0F.00	Read	Diagnostic imaging of breast	test	res22: screen_breast
7P0F000	Read	Scintimammography	test	res22: screen_breast
7P0F100	Read	Thermography of breast	test	res22: screen_breast
7P0F200	Read	Mammography	test	res22: screen_breast
7P0Fy00	Read	Other specified diagnostic imaging of breast	test	res22: screen_breast
7P0Fz00	Read	Diagnostic imaging of breast NOS	test	res22: screen_breast
8HT8.00	Read	Referral to mammography clinic	test	res22: screen_breast
8HTI.00	Read	Referral to breast clinic	test	res22: screen_breast
9N0A.00	Read	Seen in breast clinic	test	res22: screen_breast
9N1y900	Read	Seen in breast clinic	test	res22: screen_breast
9Np2.00	Read	Seen in fast track suspected breast cancer clinic	test	res22: screen_breast
9OH9.00	Read	Breast screen abnorm.-told pat	test	res22: screen_breast
9OHZ.00	Read	Breast screening administr.NOS	test	res22: screen_breast
9Oq8.00	Read	Attended breast screening clinic	test	res22: screen_breast
R138.00	Read	[D]Breast imaging abnormal	test	res22: screen_breast
R138000	Read	[D]Mammogram abnormal	test	res22: screen_breast
R138z00	Read	[D]Breast imaging abnormal NOS	test	res22: screen_breast
ZV76100	Read	[V]Screening for malignant neoplasm of breast	test	res22: screen_breast
L0010CB	OXMIS	SEEN IN MAMMOGRAPHY CLINIC	test	res22: screen_breast
L0010GB	OXMIS	REFERRED TO MAMMOGRAPHY CLINIC	test	res22: screen_breast
X9110	OXMIS	MAMMOGRAM	test	res22: screen_breast
X9111	OXMIS	MAMMOGRAM NORMAL	test	res22: screen_breast
X9111AB	OXMIS	MAMMOGRAM ABNORMAL	test	res22: screen_breast
Y060 E	OXMIS	BREAST SCREENING EXAMINATION	test	res22: screen_breast
Y1000HB	OXMIS	BREAST SCREENING	test	res22: screen_breast
Y600 EN	OXMIS	BREAST SCREENING EXAMINATION NORMAL	test	res22: screen_breast

0 comments have been posted.

Please log in to leave a comment.

Quick links:

Code list links:

Only the original uploading author or an administrator can add, edit or delete this article and its associated codes.

ClinicalCodes is a project at the University of Manchester Institute of Population Health

The ClinicalCodes project is funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)

ClinicalCodes.org